Mirus AB SG
Overview
- 1% active benzalkonium chloride-based topical antimicrobial concentrate
- Produced under appropriate cGMP controls and FDA protocols for Over The Counter (OTC) Active Drug Ingredients
- Readily 10X dilutable, conforming to FDA benzalkonium chloride monograph for “leave-on” topical antimicrobials at 0.1-0.13%
- Produces non-comedogenic sheer thinning gel at skin-friendly pH
- Non-flammable, alcohol-free, gel formula optimized for broad spectrum efficacy with skin-friendly moisturizing and conditioning ingredients, that carries the same FDA “Drug Claim” as alcohol-based alternatives
Regulatory
The substances in Mirus AB SG are listed on and in compliance with the following Inventories: US (TSCA), Canada (DSL), Europe (EINECS), Australia (AICS), China (IECSC), Japan (ENCS), Korea (ECL), New Zealand (NZIoC), Philippines (PICCS) FDA Establishment Identification number: 3010203410
Technical Information
Mirus AB SG is a 1% active benzalkonium chloride-based antibacterial hand sanitizer gel 10X concentrate. Produced under appropriate cGMP controls and FDA protocols for Over-The Counter (OTC) Active Drug Ingredients, Mirus AB SG conforms to FDA guidelines for use as an OTC Topical Antimicrobial/”leave-on” antibacterial hand sanitizer.
With the same “Drug Claim” as alcohol-based alternatives, Mirus AB SG 10X concentrate produces a clear, non-alcohol gel that is an effective alternative to gelled-alcohol-based hand sanitizer products. Mirus AB SG gel formulations meet the FDA Drug Claim “reduces bacteria on the skin” leaving the skin with a soft, refreshing and silky afterfeel. Unique skin-friendly pH gel system with an active ingredient that doesn’t evaporate with rub-out, a pea-sized drop of Mirus AB SG RTU provides total coverage.